Action Stock Transfer Corporation, 2469 Fort Union Blvd #214, Cottonwood Heights, UT 84121. Email email@example.com
No online access exists. Please email Action Stock Transfer at firstname.lastname@example.org.
Please email Action Stock Transfer at email@example.com.
ProLung common stock is not currently traded.
Most investor information is available on this website. If you wish to have news releases and other information sent to you via email, please visit our Stay Connected page to sign up for regular updates (https://ioniqsciences.com/stay-connected/) or email us at firstname.lastname@example.org.
Malone Bailey, LLP in Houston, TX.
Primary legal counsel is McDermott Will & Emery, LLP in New York, NY. Legal counsel for our IPO is Parr Brown Gee & Loveless in in Salt Lake City, UT.
ProLung’s fiscal year ends on December 31st.
We will issue a quarterly release inconjunction with the filing of our Form 10Q, which will be within 45 days of quarter end.
There are two classes of stock (preferred and common). Only shares of common stock are issued and outstanding.
No, ProLung currently expects to retain its earnings to finance the growth and development of its business and does not expect to declare or pay any cash dividends in the foreseeable future.
ProLung’s CUSIP number is 74348P209.